The company received a fresh equity infusion in 2012-13.
Many analysts find market expensive, even at current levels.
The company has a market capitalisation of $743 billion.
There, however, has been an improvement in operating margins.
Tech major's shareholders will receive total dividend of Rs 15,474 crore in FY15
For equity investors, the risk-to-reward ratio is worsening.
It was a year of big gains for equity investors.
Corporates' forex borrowings have grown at a CAGR of 15.6% since 2008.
Uncertainty lingers in the minds of retail investors due to scams.
Corporate India at present is more indebted than all state govts put together.
Bupa and Axa have already declared their intention to raise stakes.
Through the past 12 months, the Bank Nifty has risen 55%
Dilip Shanghvi founded Sun Pharma in 1983.
How both brokers and NSEL misled the investors.
Stock prices is due to valuation expansion
These plans aren't likely to put substantial cash in your hands.
Face Rs 1,000-cr minimum alternate tax demand
HUL, UltraTech, Asian Paints, L&T, HDFC Bank top global valuation charts
Sales expansion also down 4.4%
The rating system requires more transparency and better communication because it lies to employees
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances